Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Heartflow (HTFL) Cash & Equivalents (2023 - 2025)

Heartflow has reported Cash & Equivalents over the past 3 years, most recently at $44.8 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 12.83% year-over-year to $44.8 million; the TTM value through Dec 2025 reached $44.8 million, down 12.83%, while the annual FY2025 figure was $44.8 million, 12.83% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $44.8 million at Heartflow, down from $291.2 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $291.2 million in Q3 2025 and troughed at $44.8 million in Q4 2025.
  • A 3-year average of $104.3 million and a median of $75.4 million in 2024 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: crashed 58.16% in 2024 and later soared 350.3% in 2025.
  • Year by year, Cash & Equivalents stood at $122.8 million in 2023, then crashed by 58.16% to $51.4 million in 2024, then dropped by 12.83% to $44.8 million in 2025.
  • Business Quant data shows Cash & Equivalents for HTFL at $44.8 million in Q4 2025, $291.2 million in Q3 2025, and $80.2 million in Q2 2025.